PATENT CLAIM ANALYSIS

Application Number: 16449048
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-10
Patent Classification: ["514", "217000"]

Abstract:
The present disclosure relates to the treatment of various diseases and conditions with eslicarbazepine acetate. The present disclosure also relates to the use of eslicarbazepine acetate in a method for reducing or decreasing epileptic seizures in a patient. The present disclosure also relates to a method for increasing the exposure to eslicarbazepine in a patient. The present disclosure also relates to a method of preparing a pharmaceutical composition comprising eslicarbazepine acetate.

Claim (Index 35):
The method of  claim 31 , wherein upon once-daily administration of the about 1200 mg of eslicarbazepine acetate, the number, duration, or frequency of seizures in the patient decreases relative to the number, duration, or frequency of seizures in a patient without treatment.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 100.0
- Lexical Diversity: 2.20588
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16449057', '14134843', '14240847', '13387538', '15191068']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7170452079774277
- 35 USC 102 Novelty (BERT): 0.6044085681931648
- Combined Prediction Score: 0.7057815439990014
- Mean Citation Score: 347.55288600000006
- Max Citation Score: 569.4841
- Similarity Product: 472.5925344950795

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test